Adenovirus ELA protein and cyclic AMP cooperate to induce transcription factor AP-1 and viral gene expression in mouse S49 cells. We report that a protein encoded within the viral E4 gene region acts to counterbalance the induction of AP-1 DNA-binding activity by EIA and cyclic AMP. Studies with mutant adenoviruses demonstrated that in the absence of E4orf4 protein, AP-1 DNA-binding activity is induced to substantially higher levels than in wild-type virus-infected cells. The induction is the result of increased production of JunB and c-Fos proteins. Hyperphosphorylated forms of c-Fos and EIA proteins accumulate in the absence of functional E4orf4 protein. We propose that the E4orf4 protein acts to inhibit the activity of a cellular kinase that phosphorylates both the ElA and c-Fos proteins. Phosphorylation-dependent alterations in the activity of c-Fos, ElA, or some unidentified protein might, then, lead to decreased synthesis of AP-1 components. This E4 function likely plays an important role in natural infections, since a mutant virus unable to express the E4orf4 protein is considerably more cytotoxic than the wild-type virus.
Adenovirus ElA proteins appear to activate transcription through multiple mechanisms, including modification of cellular transcription factors, binding to transcription factors, and causing an increase in the levels of transcription factors. Modification can be achieved by altering the association of transcription factors with other cellular proteins. For example, the ElA proteins bind to the retinoblastoma protein, removing it from an association with E2F (4, 11, 12) and presumably freeing it to activate transcription. Modification might also be achieved by protein phosphorylation through ElA-associated kinases (24, 41, 82, 86) . Indeed, the phosphorylation state of transcription factors TFIIIC, E2F, and E4F has been reported to be altered in infected cells (3, 36, 67) . Physical interaction of ElA with a variety of cellular transcription factors (TFIID, AP-1, CRE-BP1/ATF2, and Oct-4) has been reported (37, 45, 53, 74) , indicating that ElA proteins can function within a transcription complex. Finally, the amount of some cellular transcription factors (e.g., AP-1) is increased in the presence of ElA proteins (reviewed in reference 77).
AP-1, composed of polypeptides encoded by members of the fos and jun gene families (reviewed in references 16 and 85) , has been linked to transcriptional regulation by ElA in both mouse S49 and human HeLa cells. Originally, it was noticed that many ElA-inducible viral promoters contain the cyclic AMP (cAMP)-responsive element CRE, which serves as a binding site for both the AP-1 and ATF/CREB families of transcription factors (10, 27, 28, 30, 35, 39, 44, 46, 48, 56, 59, 62, 71) . Subsequently it was shown that cAMP can activate the expression of ElA-inducible viral genes and that ElA can activate transcription through CRE. Members of both the AP-1 and ATF/CREB families have been implicated in mediating the transcriptional activation effect of ElA and cAMP (10, 19, 30, 39, 46-49, 57, 59, 60, 65, 72) . A link between transcriptional activation by ElA, cAMP, and transcription factor AP-1 was established in mouse S49 cells, in which ElA protein and cAMP cooperate to induce adenovirus gene expression and AP-1 DNA-binding activity with similar kinetics, suggesting that AP-1 activates viral gene expression (21, 59 ). Both the 243-and 289-amino-acid ElA proteins cooperate with cAMP to induce AP-1 activity, albeit with different efficiencies (22) . More recently, de Groot et al. (19) reported ElA-dependent activation of AP-1 DNA-binding activity in infected HeLa cells. AP-1 DNAbinding activity is elevated by increased synthesis of AP-1 components in both S49 and HeLa cells. Transient transfection assays confirm that AP-1 DNA-binding sites can confer enhanced ElA responsiveness to heterologous promoters (10, 19, 60, 79) . Interestingly, ElA proteins can cooperate with c-Jun, a component of AP-1, to activate transcription via AP-1 sites (19) . Depending on the promoter construct tested and the experimental conditions employed, ElA is also able to repress transcription through AP-1 sites, suggesting that ElA regulates AP-1 activity in a complex manner (19, 63) .
Our previous findings with S49 cells established a role for cAMP-dependent protein kinase A (PKA) in the induction of AP-1 activity by ElA and cAMP (59) . Similarly, induction of viral gene expression by these stimuli was dependent on PKA (21) . Both ElA proteins and AP-1 components are phosphorylated at multiple sites (5, 15, 17, 58, 69, 78, 90) .
Alterations in the phosphorylation state by cellular kinases such as PKA may alter the activity of these proteins. In the case of ElA protein, mutational analysis has failed to establish a role for the phosphorylation sites in the transcriptional activation properties of the protein (20, 81) . In contrast, the phosphorylation state of AP-1 components can modulate their transcriptional activation potential in both positive and negative manners. Phosphorylation in a domain adjacent to the DNA-binding domain prevents DNA binding and transcriptional activation by c-Jun (8) . Increased phos-phorylation in the transcriptional activation domain of c-Jun increases the ability of c-Jun to activate transcription without an effect on its DNA-binding activity (6, 66) . Mutational analysis suggests that phosphorylation sites within the C terminus of the c-Fos protein are essential for the ability of c-Fos to negatively regulate its own promoter (64) .
The effects of protein phosphorylation on the activity of AP-1 components led us to search for PKA-dependent alterations in the phosphorylation of AP (40, 54) . Each experiment was carried out with at least two independently grown stocks of virus to ensure reproducibility. The following mutant viruses used in this study have been described elsewhere: d1343 (32); d1347 and d1348 (89); d1312 and d1313 (40) ; d1802 (68); d1327 (80); d1339 (50); d1355, d1356, d1358, and d1366 (29) ; and dl1003, dl1006, and d11014 (9).
In general, infections of exponentially growing S49 and BlR cells were carried out as described previously (59) (59) .
The preparation of cytoplasmic RNA and RNase protection protocols have been described by Engel et al. (21) . The c-fos probe was a gift from M. Cole, and the junB probe was provided by D. Nathans (The Johns Hopkins School of Medicine).
Nuclear run-on assays were carried out as described by Greenberg and Ziff (25) , with some modifications. S49 nuclei were prepared (59) and resuspended at a density of 107/100 ,ul in solution I (50 mM 9 .5], 100 mM NaCl, 5 mM MgCl2) and incubated in AP buffer supplemented with 5-bromo-4-chloro-3-indolylphosphate toluidinium (15 mg/100 ml) and nitroblue tetrazolium (30 mg/100 ml). The color reaction was stopped by rinsing the filters extensively in H20.
Monoclonal ElA antibody M73 and c-Fos antiserum, gifts from E. Harlow (Massachusetts General Hospital) and T. Curran (Roche Institute of Molecular Biology), have been described elsewhere (18, 31) . JunB antiserum was provided by R. Bravo (Bristol-Myers Squibb). It is a polyclonal rabbit antiserum and specific for the JunB protein.
RESULTS
Altered phosphorylation of ELA proteins after cAMP treatment. We previously reported that ElA protein and cAMP cooperate to induce transcription factor AP-1 in adenovirusinfected S49 cells (59) . S49 cells were employed for these experiments, since unlike HeLa cells, the more common adenovirus laboratory host, they are highly responsive to cAMP. Furthermore, S49 sublines with deficiencies in the cAMP-triggered signal transduction pathway are available. One of these cell lines, BlR (7, 14) (20, 31, 69, 81) . All four bands were evident in extracts from wild-type (wt300) virus-infected cells (Fig. 1A , 0-h cAMP). Changes in the mobility of ElA proteins, indicative of changes in their phosphorylation, were observed when extracts from cAMP-treated cells were analyzed. Alterations in the mobility of ElA proteins were first evident after cAMP treatment for 1 h (data not shown) and became pronounced by 3 h (Fig. 1A) . The intensity of the bands designated 289-1 and 289-2 decreased after extended periods of cAMP treatment (see Fig. 2B ), while bands of faster mobility, 289-3 and 289-4 (identified as 289 specific in d1348-infected cells; data not shown), accumulated (Fig. 1A ). There also appeared to be a slight increase in the proportion of less-phosphorylated relative to highly phosphorylated 243-amino-acid ElA protein (243-1 versus 243-2, Fig. 1 (Fig.  1B) . This confirmed the fact that the different ElA-specific bands detected in these experiments corresponded to differentially phosphorylated polypeptides.
Analyses of ElA proteins by two-dimensional phosphotryptic maps further indicated that the electrophoretic variants observed after cAMP treatment indeed corresponded to hypophosphorylated ElA protein (Fig. 1C) . Multiple tryptic phosphopeptides could be identified in ElA proteins extracted from wild-type virus-infected cells. At least one of the major phosphopeptides was missing from the ElA protein extracted 3 h after cAMP treatment, confirming that ElA becomes hypophosphorylated upon treatment of infected cells with cAMP. We have not identified the amino acid(s) whose phosphorylation is altered. However, we can rule out, with a fair degree of confidence, the major phosphorylation sites at Ser-89 and -219. Tryptic peptides containing these phosphorylated residues have been identified previously (20, 81, 83) , and spots corresponding to these peptides were not altered in our experiment. Fig. 2A ). To identify which of the orfs encodes the viral function required for the phosphorylation change, we evaluated a series of mutant viruses carrying deletions within the E4 gene region (Fig. 2A) . The results for some viruses are shown in Fig. 2B and summarized in Table   1 . All mutants that carried deletions affecting orf4 (d1366, d11003, and d1358) were unable to cooperate with cAMP in (Table 1) .
We also analyzed the phosphorylation changes of ElA protein by pulse-chase experiments (Fig. 2C) . Two bands representing different phosphoforms of the 289-amino-acid protein were evident in d1366-and d1358-infected, cAMPtreated cells after 10 min of pulse labeling, and the hypophosphorylated band was readily chased into the more highly phosphorylated form within 1 h. In contrast, only the hypophosphorylated, faster-migrating form accumulated to substantial levels in wt300-infected cells, and it was not chased into a more highly phosphorylated form, even after 2 h. Phosphorylation changes in the 243-amino-acid ElA protein were not evident. Our data suggest that the accumulation of hypophosporylated 289-amino-acid ElA protein in infected cells resulted from inhibition of a kinase by the E4orf4 product. However, we cannot exclude the possibility that a phosphatase which removed phosphate from newly synthesized ElA protein was activated. If a phosphatase was involved, it must have been activated slowly over at least 1 h, since this was the first time after cAMP treatment when hypophosphorylated ElA protein was evident.
To determine whether E4orf4 proteins would influence the phosphorylation of ElA proteins in HeLa cells, the cells were infected with wt300, d1366, or d1358 and ElA proteins were analyzed by immunoprecipitation of 35S-labeled extracts prepared at various times during the infection cycle (Fig. 2D) . Two different phosphoforms of the 289-amino-acid ElA protein were present in equimolar amounts in d1366-and d1358-infected cells throughout the time course. In contrast, the less-phosphorylated form predominated in wt300-infected cells. in adenovirus-infected cells (38) , but phosphorylation of the protein was not influenced by cAMP treatment (data not shown). Additionally, we observed no changes in the phosphorylation of the viral E1B 55-kDa protein (data not shown) or the JunB protein (see Fig. 3C and SB) when we analyzed them by immunoprecipitation from 35S-or 32P-labeled extracts. In contrast, the phosphorylation of the c-Fos protein, a component of transcription factor AP-1, was altered in infected and cAMP-treated cells in an E4orf4-dependent manner. Figure 3A (Fig. 3B) , and labeling with 32p confirmed a reduced level of phosphate incorporation into c-Fos protein in wt300-infected compared with uninfected or d1358-infected S49 cells (Fig. 3C and data not shown) . Similar results were obtained in a pulse-chase experiment iFig. 3D). In d1366-and d1358-infected cells, a portion of the 5S-labeled c-Fos protein could be chased within 30 min into two more slowly migrating and presumably more highly phosphorylated forms. In contrast, in wt300-infected cells, c-Fos could be chased only into the faster migrating of the two more slowly migrating forms, suggesting that a specific phosphorylation step was blocked.
Thus, we conclude that phosphorylation of both the c-Fos and ElA proteins in infected, cAMP-treated S49 cells is regulated by the E4orf4 protein. E4orf4 protein specifically altered some, but not other, phosphorylation events, suggesting that only one of multiple kinases (or phosphatases) was affected. We were not able to determine whether the alterations in the phosphorylation of c-Fos were dependent on PKA, since the induction of c-Fos protein itself was entirely dependent on PKA in S49 cells. E4orf4 regulates the level of AP-1. Since c-Fos is a component of AP-1, we determined whether the change in c-Fos phosphorylation would alter the physical properties of AP-1 or its level of DNA-binding activity. We searched for changes in the bound half-life of AP-1-DNA complexes or in binding specificity for a variety of different recognition sites, but no alterations were observed (data not shown), suggesting that the DNA-binding properties of AP-1 were not influenced by the phosphorylation events under study. However, induction of AP-1 DNA-binding activity by cAMP was altered in E4 mutant-infected versus wild-type virus-infected cells (Fig. 4) . S49 cells were infected with the wt300 or E4 mutant virus, nuclear extracts were prepared after various times of cAMP treatment, and AP-1 levels were analyzed by DNA band shift assay. As reported earlier for wt300-infected cells (59) , treatment with cAMP led to a transient increase in AP-1 DNA-binding activity, which reached maximal levels around 2.5 to 5 h after addition of cAMP and decreased thereafter. In contrast, the induced AP-1 activity reached higher levels and remained elevated for a longer time in cells infected with viruses lacking the entire E4 gene (d1366) or E4orf4 (d1358). As in wt300 infections, maximal levels of AP-1 were induced after 2.5 to 5 h of cAMP treatment but levels stayed high for at least 24 h, the last time point tested. The effect was reproducibly somewhat more pronounced for d1366 than d1358 infections, and it was specific for AP-1 activity since no effect was observed for two other transcrip- (59) . Experiments were carried out to determine whether the phosphorylation state of c-Fos influences its ability to associate with JunB. 35S-labeled extracts were prepared, and immunoprecipitations were performed by using antibodies to JunB-or c-Fos (Fig. 5 ).
More labeled extract from wild-type virus-infected than mutant virus-infected cells was employed to generate equivalent amounts of immunoprecipitated proteins (d1358-infected cells contain more c-Fos and JunB; see Fig. 7 ).
Immunoprecipitation of c-Fos from extracts of wt300 and d1358-infected cells confirmed that the c-Fos protein in d1358-infected cells included species with slower mobility on denaturing polyacrylamide gels than the c-Fos protein from wt300-infected cells, indicative of a difference in its phosphorylation state (Fig. SA) . Three JunB-specific polypeptides were coimmunoprecipitated with c-Fos. The identity of the JunB polypeptides was revealed by immunoprecipitation with a JunB-specific antibody, and all three bands were shifted into one band by phosphatase treatment, indicating that they represented different phosphoforms of JunB (Fig.   SB) . As expected, the three phosphoforms of JunB coimmunoprecipitated with c-Fos antibodies from native, but not denatured, extracts. All three phosphoforms of JunB were evident in extracts from both wt300-and d1358-infected cells, and they coimmunoprecipitated in equal amounts with the different c-Fos phosphoforms (Fig. SA) . Thus, the interac- Immunoprecipitation were performed with a c-Fos antibody using 35S-labeled total cell extracts from wt300-and d1358-infected cells. Where indicated, the cells had been treated for 3 h with cAMP prior to extract preparation. c-Fos, JunB, and Fra-specific bands are labeled. As a control, ElA and associated proteins were immunoprecipitated from the wt300-infected cell extract by using antibody The data in Fig. 5 also confirmed that phosphorylation of the JunB protein, at least as analyzed by one-dimensional gel electrophoresis, was not detectably affected by the E4orf4 mutation.
Mechanism of AP-1 regulation by E4orf4. The increased accumulation of AP-1 DNA-binding activity in E4 mutant virus-infected cells could result from alterations in the rate of transcription or translation of AP-1 components. Alternatively, alterations in the phosphorylation of c-Fos might change the half-life of c-Fos protein and AP-1 complexes. Experiments were performed to distinguish among these possibilities.
RNase protection experiments revealed that c-fos and junB mRNAs increased to peak levels within 1 h of cAMP treatment of wild-type or mutant virus-infected cells (Fig.  6A) . Both mRNAs returned nearly to basal levels by 3 h after cAMP treatment of wild-type virus-infected cells. In contrast, levels ofjunB mRNA remained elevated for extended periods after cAMP treatment in E4 mutant-infected cells: at least 10 h for d1358 and 24 h for d1366. The difference between the two mutants was reproduced in multiple independent experiments and is consistent with the difference observed for AP-1 DNA-binding activity (Fig. 4) . Less c-fos than junB mRNA was present at all times tested, and the level of c-fos mRNA also appeared to remain somewhat elevated for a longer time in d1366-infected cells than in cells infected with wt300 (compare 3-and 5-h time points, Fig.  6A ). However, the effect was much less dramatic than that observed for junB mRNA.
We confirmed by nuclear run-on experiments (Fig. 6B ) that the increased accumulation of junB mRNA was the result of an increased transcription rate of the junB gene. In wt300-infected cells, the transcription rates of both the c-fos and junB genes were induced to peak levels within 30 min of cAMP treatment and decreased after 1 h. In d1366-infected cells, junB and c-fos transcription was also induced within 30 min. However, even though the junB transcription rate was reduced after 1 h, it remained elevated above basal levels for at least 8 h, the last time point tested. Transcription of the c-fos gene remained only slightly above basal levels (1.5-fold) at 4 h after cAMP treatment was initiated. This marginal enhancement is consistent with the slight increase observed for c-fos mRNA levels. Treatment with cAMP had no effect on c-myc expression, which served as a control.
We next examined the half-life and synthesis rate of the JunB and c-Fos proteins. The stability of the two proteins was the same in d1366-, d1358-, and wt300-infected cells (Fig.  3B and data not shown) 7A) . Substantially more JunB protein was synthesized at 5 and 10 h after the start of cAMP treatment in mutant-infected than in wild-type virus-infected cells. The enhanced rate of JunB synthesis (Fig. 7A ) appears to be a direct consequence of its enhanced mRNA levels (Fig. 6) . After 2.5 h of cAMP treatment, the rate of c-Fos protein synthesis was enhanced to a greater extent in mutant-infected than in wild-type virus-infected cells (wt300, 1.5-fold; d1366, 5-fold; d1358, 5-fold [ Fig. 7B] ). Further, an enhanced level of c-Fos synthesis was maintained for a longer time after cAMP treatment in mutant-infected than in wild-type virus-infected cells (e.g., compare the 24-h assays for wt300 and d1366, Fig. 7B ). Overall, then, more c-Fos protein is synthesized after cAMP treatment in mutant virus-infected cells than in cells infected with wild-type virus.
It is difficult to be certain whether the modulation of c-Fos by the E4orf4 gene product is due entirely to its modest effect on transcription. A translational component might also be involved. It is, nevertheless, clear that the E4 protein affected JunB accumulation primarily at the level of transcription.
E4orf4 reduces virus-mediated cytotoxicity. It seemed likely that a persistently high level of a regulatory molecule such as AP-1 could adversely affect the cell, so we determined whether the E4orf4 mutant was more toxic than the wild-type virus. Rat fibroblasts (CREF cells) were employed for the assay, since they are nonpermissive for adenovirus type 5, permitting expression of early but not late viral genes. Cells were infected with d1358 or wt300 and then assayed for colony formation to assess the number of viable cells (Table 2) . Infection with the wild-type virus reduced the number of colonies by about 40%. However, the mutant (Fig. 1 to 3 ). Accumulation of hypophosphorylated proteins is prevented in the presence of a chemical PKA blocker or in BlR cells (data not shown), indicating that PKA is required for the E4orf4-mediated hypophosphorylation event. The simplest explanation for this requirement is that PKA is needed to induce transcription of the E4 unit in cooperation with ElA protein (21) to generate sufficient quantities of the E4orf4 protein which, in turn, induce hypophosphorylation. However, we cannot rule out an additional, more direct role for PKA in the process. E4orf4 protein also regulates the phosphorylation of ElA in HeLa cells, even in the absence of exogenously applied cAMP (Fig. 2D) . PKA is constitutively activated in HeLa cells, owing to high endogenous levels of cAMP (54a).
(ii) The E4orf4 protein plays a central role in the regulated induction of AP-1 DNA-binding activity by ElA and cAMP. AP-1 DNA-binding levels are higher, and stay elevated for longer times (24 versus 5 h), in E4orf4 mutant-infected cells than in wild-type virus-infected cells (Fig. 4) . The increase in AP-1 DNA-binding activity is due to enhanced accumulation of the JunB and c-Fos proteins. Expression of junB is modulated at the level of transcription, and c-fos might be influenced at both the transcriptional and the translational levels ( Fig. 6 and 7) . (iii) The E4orf4 protein reduces the cytotoxic effect of early viral gene expression (Table 2 ). This might result from the altered ElA and c-Fos phosphorylation or the reduction in AP-1 activity, but we have no evidence for cause and effect beyond the correlation. Such a protective role could be important in natural infections, in which adenoviruses maintain long-term associations with their infected hosts.
Induction of AP-1 DNA-binding activity by ElA and cAMP is a transient process. The degree and duration of the induction is apparently regulated by the E4orf4 protein, since AP-1 DNA-binding activity reaches higher levels and remains elevated for an extended time after cAMP treatment in the absence of the E4 product. We observed repeatedly that AP-1 was induced to even higher levels when the total E4 transcription unit, rather than just orf4, was deleted.
Conceivably, a second E4 protein contributes to the regulation of AP-1 accumulation. Nevertheless, the process was clearly dependent on the E4orf4 protein, since increased accumulation of AP-1 activity was not observed upon infection with d11014, which contains only orf4 in its E4 region (Table 1) .
Hypophosphorylation and down regulation of AP-1 DNAbinding activity could not be uncoupled by the use of mutants (Table 1) We favor the hypothesis that the change in c-Fos phosphorylation is key to the regulation of AP-1 DNA-binding levels. In fact, c-Fos may contribute to the differential regulation of junB and c-fos promoter activities we have observed (Fig. 6B) . It has previously been demonstrated that c-Fos, as part of AP-1, can activate the expression of a variety of target genes, including the c-jun gene (13, 52, 75) . c-fos can also negatively regulate its own promoter (73, 75, 88) , independently of its ability to bind as part of AP-1 to AP-1 sites within the c-fos transcriptional control region. Repression is mediated by the serum response element within the c-Fos regulatory region and requires C-terminal amino acids of the c-Fos protein, a domain that is not required to form active AP-1 complexes (26, 42, 51, 70, 88) . In vitro transcription studies also indicate that the c-Fos protein contains independent repression and activation domains (1, 2) . The c-Fos protein is phosphorylated at multiple sites, some of which are located in the C terminus of the protein (5, 17, 58) . It is conceivable that the phosphorylation state of c-Fos differentially influences its repression or activation function. It has recently been demonstrated that point mutations which prevent phosporylation in the C terminus of c-Fos abolish its ability to negatively regulate the c-fos promoter (72) . Perhaps the E4orf4 protein regulates the phosphorylation status of sites within the transactivation domain of c-Fos but not in the C-terminal domain involved in repression. This could lead to an increased transactivation potential of c-Fos in the absence of E4orf4 protein without an effect on negative autoregulation. As a consequence, in E4orf4 mutant virus infections, c-fos transcription would be transiently induced, while expression of junB could be enhanced on a continuing basis. In agreement with this hypothesis, a sequence element resembling the AP-1 motif has been identified within the promoter of the human junB gene (76) .
This model for regulation of c-Fos activity by phosphorylation shows an interesting parallel to the regulation of c-Jun activity. Two different phosphorylation domains have been identified within the c-Jun protein. One of the domains is located adjacent to the DNA-binding domain and, if phosphorylated, prevents DNA binding and transcriptional activation by c-Jun (8) . The second domain is contained within the transcriptional activation domain of c-Jun; when phosphorylated, it increases the transactivation potential of c-Jun without an influence on its DNA-binding activity (6) . Phosphorylation can be induced by ras and may be mediated by MAP-1 kinase (66).
Although we cannot definitively rule out the action of a phosphatase, it seems likely that the accumulation of hypophosphorylated ElA and c-Fos proteins resulted from inhibition of a kinase. This assertion follows from two findings. (i) Hypophosphorylated ElA proteins accumulated rather slowly; fully phosphorylated forms of ElA were still detectable after 1 h of cAMP treatment, although in reduced amounts. This suggests that fully phosphorylated ElA proteins were not actively dephosphorylated but rather turned over within 1 to 2 h owing to their relatively short half-life.
(ii) Pulse-chase experiments show that in wt300-infected cells both the c-Fos protein and the ElA 289-amino-acid ElA protein were not phosphorylated to completion during the chase period ( Fig. 2C and 3D ). Partially phosphorylated c-Fos and ElA proteins accumulated during the chase period, suggesting that they may be phosphorylated by several different kinases, one of which is regulated in virus-infected cells. A cellular kinase could be inhibited by direct binding of the E4orf4 protein, which would then serve as a negatively acting regulatory subunit; however, it is equally possible that the viral protein initiates a cascade of events, leading to inhibition by a more indirect mechanism. Alternatively, PKA may play a more direct role in the process than simply participation in induction of the E4orf4 protein. PKA could phosphorylate a kinase to regulate its activity or phosphorylate another protein, which in turn could regulate kinase activity. The adenovirus type 5 E4orf4 protein itself contains a PKA consensus phosphorylation site, suggesting that it is a regulatory molecule activated by PKA. It should be noted, however, that the consensus phosphorylation site is not conserved in the E4orf4 proteins of all adenovirus serotypes.
